BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Singh S, Usman K, Banerjee M. Pharmacogenetic studies update in type 2 diabetes mellitus. World J Diabetes 2016; 7(15): 302-315 [PMID: 27555891 DOI: 10.4239/wjd.v7.i15.302]
URL: https://www.wjgnet.com/1948-9358/full/v7/i15/302.htm
Number Citing Articles
1
Poongothai Venkatachalapathy, Sruthi Padhilahouse, Mohan Sellappan, Tharunika Subramanian, Shilia Jacob Kurian, Sonal Sekhar Miraj, Mahadev Rao, Ashwin Ashok Raut, Rupinder Kaur Kanwar, Jitendra Singh, Sagar Khadanga, Sukumar Mondithoka, Murali Munisamy. Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical PracticePharmacogenomics and Personalized Medicine 2021; : 1441 doi: 10.2147/PGPM.S329787
2
Yulia Nasykhova, Yury Barbitoff, Ziravard Tonyan, Maria Danilova, Ivan Nevzorov, Tatiana Komandresova, Anastasiia Mikhailova, Tatiana Vasilieva, Olga Glavnova, Maria Yarmolinskaya, Evgenia Sluchanko, Andrey Glotov. Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes MellitusGenes 2022; 13(8): 1310 doi: 10.3390/genes13081310
3
Anna-Therese Lehnich, Wolfgang Rathmann. Pharmakogenetik neuer Glukosespiegelsenker: eine Chance für die Präzisionsmedizin?Die Diabetologie 2023; 19(2): 124 doi: 10.1007/s11428-022-00993-3
4
Yan Chen, Ying Zhao, Yan-Bo Li, Yan-Jun Wang, Gui-Zhen Zhang. Detection of SNPs of T2DM susceptibility genes by a ligase detection reaction–fluorescent nanosphere techniqueAnalytical Biochemistry 2018; : 38 doi: 10.1016/j.ab.2017.11.003
5
Gaia Chiara Mannino, Francesco Andreozzi, Giorgio Sesti. Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicineDiabetes/Metabolism Research and Reviews 2019; 35(3) doi: 10.1002/dmrr.3109
6
Jing Chen, Xianjun Meng. Aronia melanocarpa Anthocyanin Extracts Improve Hepatic Structure and Function in High-Fat Diet-/Streptozotocin-Induced T2DM MiceJournal of Agricultural and Food Chemistry 2022; 70(37): 11531 doi: 10.1021/acs.jafc.2c03286
7
Mahmoud M. Sirdah, N. Scott Reading. Genetic predisposition in type 2 diabetes: A promising approach toward a personalized management of diabetesClinical Genetics 2020; 98(6): 525 doi: 10.1111/cge.13772
8
Devi Trisna Ramadhani, Rafi Amanda Rezkia Amradani, Mila Ulfia, Suryaningtyas Margi Utami, Dono Indarto, Brian Wasita. The Comparative Effect of Pomegranate Peel Extract and Dapagliflozin on Body Weight of Male Albino Wistar Rats with Type 2 Diabetes MellitusIOP Conference Series: Materials Science and Engineering 2019; 546(6): 062023 doi: 10.1088/1757-899X/546/6/062023
9
Rene Markovič, Vladimir Grubelnik, Tadej Završnik, Helena Blažun Vošner, Peter Kokol, Matjaž Perc, Marko Marhl, Matej Završnik, Jernej Završnik. Profiling of patients with type 2 diabetes based on medication adherence dataFrontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1209809
10
Maryam Mazraesefidi, Mehdi Mahmoodi, Mohammadreza Hajizadeh. Effects of silibinin on apoptosis and insulin secretion in rat RINm5F pancreatic β-cellsBiotechnic & Histochemistry 2023; 98(3): 201 doi: 10.1080/10520295.2022.2154840
11
Robert Vigersky, Maneesh Shrivastav. Role of continuous glucose monitoring for type 2 in diabetes management and researchJournal of Diabetes and its Complications 2017; 31(1): 280 doi: 10.1016/j.jdiacomp.2016.10.007
12
Francesco Liguori, Elisa Mascolo, Fiammetta Vernì. The Genetics of Diabetes: What We Can Learn from DrosophilaInternational Journal of Molecular Sciences 2021; 22(20): 11295 doi: 10.3390/ijms222011295
13
Ashwin Kumar Shukla, Komal Awasthi, Kauser Usman, Monisha Banerjee. Pharmacogenetics of Metformin Monotherapy: GSTM1/T1 Polymorphisms and T2DM RiskCurrent Pharmacogenomics and Personalized Medicine 2024; 21(2): 100 doi: 10.2174/0118756921327075240909113640
14
Elizabeth Paz-Pacheco, Jose B Nevado, Eva Maria C Cutiongco-de la Paz, Gabriel V Jasul, Aimee Yvonne Criselle L Aman, Elizabeth Laurize A Ribaya, Mark David G Francisco, Ma Luz Vicenta V Guanzon, May L Uyking-Naranjo, Ma Cecille S Añonuevo-Cruz, Maria Patricia Deanna D Maningat, Cristina V Jaring, Paulette D Nacpil-Dominguez, Aniza B Pala-Mohamad, Abigail U Canto, John Paul M Quisumbing, Annabelle Marie M Lat, Diane Carla C Bernardo, Noemie Marie M Mansibang, Karell Jo Angelique C Calpito, Vincent Sean D Ribaya, Julius Patrick Y Ferrer, Jessica H Biwang, Jodelyn B Melegrito, Christian Deo T Deguit, Carlos Emmanuel G Panerio. Variants of SLC2A10 may be Linked to Poor Response to MetforminJournal of the Endocrine Society 2022; 6(8) doi: 10.1210/jendso/bvac092
15
El Hourch Sarah, Naoual El Omri, Azeddine Ibrahimi, Rachid El Jaoudi. Metabolic and genetic studies of glimepiride and metformin and their association with type 2 diabetesGene Reports 2020; 21: 100787 doi: 10.1016/j.genrep.2020.100787
16
Hamid Reza Aghaei Meybodi, Mandana Hasanzad, Negar Sarhangi, Bagher Larijani. Precision Medicine in Clinical Practice2022; : 67 doi: 10.1007/978-981-19-5082-7_5
17
Sureka Nagarajah, Abdullah Alkandari, Pedro Marques-Vidal. Genetic risk scores: are they important for diabetes management? results from multiple cross-sectional studiesDiabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-023-01204-9
18
Maria Assunta Potenza, Carmela Nacci, Maria Antonietta De Salvia, Luca Sgarra, Massimo Collino, Monica Montagnani. Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic optionsPharmacological Research 2017; 120: 226 doi: 10.1016/j.phrs.2017.04.009
19
Na Wu, Haitao Shen, Yanjun Wang, Bing He, Yongyan Zhang, Yu Bai, Runyu Du, Qiang Du, Ping Han. Role of the PKCβII/JNK signaling pathway in acute glucose fluctuation-induced apoptosis of rat vascular endothelial cellsActa Diabetologica 2017; 54(8): 727 doi: 10.1007/s00592-017-0999-5
20
Shalini Singh, Ashwin Kumar Shukla, Kauser Usman, Monisha Banerjee. Pharmacogenetic impact of SLC22A1 gene variant rs628031 (G/A) in newly diagnosed Indian type 2 diabetes patients undergoing metformin monotherapyPharmacogenetics and Genomics 2023; 33(3): 51 doi: 10.1097/FPC.0000000000000493
21
Zainonesa Abrahams-October, Rabia Johnson, Mongi Benjeddou, Ruben Cloete. The determination of the effect(s) of solute carrier family 22-member 2 (SLC22A2) haplotype variants on drug binding via molecular dynamic simulation systemsScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21291-4
22
Elahe Mohammadi, Behzad Behnam, Reza Mohammadinejad, Paul C. Guest, Luis E. Simental-Mendía, Amirhossein Sahebkar. Studies on Biomarkers and New Targets in Aging Research in IranAdvances in Experimental Medicine and Biology 2021; 1291: 151 doi: 10.1007/978-3-030-56153-6_9
23
Marcello Tucci, Elisa Roca, Laura Ferrari, Anna Pia, Alberto Dalla Volta, Francesca Bedussi, Consuelo Buttigliero, Giorgio Vittorio Scagliotti, Sandra Sigala, Alfredo Berruti. Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agentsEndocrine 2019; 64(3): 724 doi: 10.1007/s12020-019-01947-4
24
Z Abrahams-October, L Xhakaza, B Pearce, C Mandisa Masilela, M Benjeddou, O Vincent Adeniyi, R Johnson, J Jebio Ongole. Genetic association of solute carrier transporter gene variants with metformin responseBalkan Journal of Medical Genetics 2021; 24(1): 47 doi: 10.2478/bjmg-2021-0004
25
Fangying Xie, Juliana CN Chan, Ronald CW Ma. Precision medicine in diabetes prevention, classification and managementJournal of Diabetes Investigation 2018; 9(5): 998 doi: 10.1111/jdi.12830
26
M. Kalinkova, T. Kadiyska, K. Dabchev, G. Bogdanov, T. Handjieva-Darlenska. Analysis of Genetic Polymorphisms of OCT1, MATE1, MATE2 and GLP1R in Rats with Experimentally Induced ObesityActa Medica Bulgarica 2024; 51(3): 48 doi: 10.2478/amb-2024-0041
27
Maryam Mazraesefidi , Maryam Mohammad Sadeghipour , Hossein Khorramdelazad , Mahdi Mahmoodi , Alireza Khoshdel , Mohammadali Fahmidehkar , Reza Hosseiniara , Mohammad Reza Hajizadeh. Evaluation Effects of Quercetin on Streptozotocin-treated RINm5F Pancreatic β-cells in vitroCurrent Chemical Biology 2021; 15(4): 310 doi: 10.2174/2212796816666211223101206
28
Khaled Naja, Said El Shamieh, Rajaa Fakhoury. rs622342A>C in SLC22A1 is associated with metformin pharmacokinetics and glycemic responseDrug Metabolism and Pharmacokinetics 2020; 35(1): 160 doi: 10.1016/j.dmpk.2019.10.007
29
Jing Chen, Chong Ning, Jingjing Mu, Dongnan Li, Yan Ma, Xianjun Meng. Role of Wnt signaling pathways in type 2 diabetes mellitusMolecular and Cellular Biochemistry 2021; 476(5): 2219 doi: 10.1007/s11010-021-04086-5
30
N. O. Pozdnyakov, I. N. Kagarmanyan, A. E. Miroshnikov, E. S. Emelyanov, A. A. Gruzdeva, A. M. Sirotkina, I. A. Dukhanina, A. A. Milkina, A. A. Khokhlov, S. O. Pozdnyakov. Pharmacogenetic Aspects of Type 2 Diabetes TreatmentActa Biomedica Scientifica (East Siberian Biomedical Journal) 2020; 5(3): 13 doi: 10.29413/ABS.2020-5.3.2
31
Rosario Dominguez Crespo Hirata, Alvaro Cerda, Fabiana Dalla Vecchia Genvigir, Mario Hiroyuki Hirata. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populationsBrazilian Journal of Pharmaceutical Sciences 2018; 54(spe) doi: 10.1590/s2175-97902018000001005
32
Saliha Rizvi, Syed Tasleem Raza, Farzana Mahdi. Association of Single Nucleotide Polymorphism in OCT1 and OCT3 Genes with the Efficacy of Metformin Response in North Indian Type 2 Diabetes Mellitus PatientsCurrent Pharmacogenomics and Personalized Medicine 2024; 21(2): 88 doi: 10.2174/0118756921316739240816095335
33
Jose J. G. Marin, Maria A. Serrano, Maria J. Monte, Anabel Sanchez-Martin, Alvaro G. Temprano, Oscar Briz, Marta R. Romero. Role of Genetic Variations in the Hepatic Handling of DrugsInternational Journal of Molecular Sciences 2020; 21(8): 2884 doi: 10.3390/ijms21082884
34
T. A. Kiseleva, F. V. Valeeva, D. R. Islamova. Personalized therapy of type 2 diabetes mellitusPerm Medical Journal 2023; 40(5): 73 doi: 10.17816/pmj40573-79
35
P. Żelechowska, J. Agier, E. Kozłowska, E. Brzezińska‐Błaszczyk. Mast cells participate in chronic low‐grade inflammation within adipose tissueObesity Reviews 2018; 19(5): 686 doi: 10.1111/obr.12670
36
Canjun Zhu, Zhiyue Xu, Yexian Yuan, Tao Wang, Chang Xu, Cong Yin, Peipei Xie, Pingwen Xu, Hui Ye, Nirali Patel, Sarah Schaul, Lina Wang, Xiaotong Zhu, Songbo Wang, Ping Gao, Qianyun Xi, Yongliang Zhang, Gang Shu, Qingyan Jiang. Heparin impairs skeletal muscle glucose uptake by inhibiting insulin binding to insulin receptorEndocrinology, Diabetes & Metabolism 2021; 4(3) doi: 10.1002/edm2.253
37
Ehab S. EL Desoky. Therapeutic Dilemma in Personalized MedicineCurrent Reviews in Clinical and Experimental Pharmacology 2022; 17(2): 94 doi: 10.2174/1574884716666210525153454
38
Shahrzad Manavi Nameghi. Exploring the recent advancements and future prospects of personalized medicine in type 2 diabetesEndocrine and Metabolic Science 2024; 16: 100193 doi: 10.1016/j.endmts.2024.100193
39
Yulia A. Nasykhova, Ziravard N. Tonyan, Anastasiia A. Mikhailova, Maria M. Danilova, Andrey S. Glotov. Pharmacogenetics of Type 2 Diabetes—Progress and ProspectsInternational Journal of Molecular Sciences 2020; 21(18): 6842 doi: 10.3390/ijms21186842
40
Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Marcellino Monda, Raffaele Marfella, Celestino Sardu, Teresa Salvatore, Luca Rinaldi, Ferdinando Carlo Sasso. Precision Medicine in Type 2 Diabetes Mellitus: Utility and LimitationsDiabetes, Metabolic Syndrome and Obesity 2023; : 3669 doi: 10.2147/DMSO.S390752
41
Nidia Samara Rodríguez-Rivera, Patricia Cuautle-Rodríguez, Fernando Castillo-Nájera, Juan Arcadio Molina-Guarneros. Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo populationBiomedical Reports 2017; 7(1): 21 doi: 10.3892/br.2017.921
42
Omna Singh, Madhur Verma, Nikita Dahiya, Sabyasachi Senapati, Rakesh Kakkar, Sanjay Kalra. Integrating Polygenic Risk Scores (PRS) for Personalized Diabetes Care: Advancing Clinical Practice with Tailored Pharmacological ApproachesDiabetes Therapy 2024;  doi: 10.1007/s13300-024-01676-6